AstraZeneca Broadens US Growth Push
Share
AstraZeneca CFO Aradhana Sarin discusses how the pharmaceutical company is broadening its US shareholder base and plans to generate $80 Billion in revenue by 2030. She speaks with Bloomberg's Katie Greifeld.
More from Australia
NRFC commits up to $110M for Victorian rare earths project
Wide Open Agriculture extends China distribution deal to 2028
Polymetals Resources generates $31M sales from Endeavor Mine
H3 Energy finds deeper gas targets at Warro gas field
BSP Financial Group quarterly net profit reaches K334M
Resonance Health secures $6M share placement